Avara Management Ltd, 10% Owner, Director at Royalty Pharma plc (RPRX), sold 65,186 shares at $41.05 ($2.7M) on 2022-09-28, disclosed to the SEC on 2022-09-30.
Open-market sale of $2.7M RPRX by 10% Owner, Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.05 | 32,593 | $1.3M | 50.0% |
| 2 | $41.05 | 32,593 | $1.3M | 50.0% |
| Total | $41.05 avg | 65,186 | $2.7M | 100% |
| Filing → |
| RPRX | SELL | 2022-12-07 | $7.3M | — | Filing → |
| RPRX | SELL | 2022-09-26 | $17.4M | — | Filing → |
| RPRX | SELL | 2022-09-09 | $42.7M | — | Filing → |